FDA Inspection
Jajco, Inc. DBA Anchor Drugs PharmacyJajco, Inc. DBA Anchor Drugs Pharmacy – FDA Inspection, Jun 3, 2016
Record Details
This FDA Inspection record concerns Jajco, Inc. DBA Anchor Drugs Pharmacy, with an inspection on June 3, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 3, 2016
- Product Type
- Drugs
View Company Profile
ID · 474d56bc-2400-4faf-b2d2-4157ea02c3c5
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 974160
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.42(c)(10)(iii)Air Supply
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.28(a)Clothing appropriate for duties performed
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.166(a)Lack of written stability program
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Jajco, Inc. DBA Anchor Drugs Pharmacy
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 29, 2018 | Not classified | San Francisco District Office | Drug Quality Assurance |
Other documents for Jajco, Inc. DBA Anchor Drugs Pharmacy
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.